All products are for Professional Use Only (PUO) — not intended for human or animal consumption

Back to Learn
Cognitive & LongevityPeptide

SS-31 (Elamipretide)

A mitochondria-targeted tetrapeptide that selectively binds to cardiolipin in the inner mitochondrial membrane. Studies have investigated its effects on mitochondrial function in research models of heart failure and mitochondrial myopathy.

Mechanism of Action

SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2, also known as elamipretide or MTP-131) is a cell-permeable, mitochondria-targeted peptide that concentrates >1000-fold in mitochondria. It selectively binds to cardiolipin, a phospholipid unique to the inner mitochondrial membrane that is essential for the organization of electron transport chain complexes. By stabilizing cardiolipin-dependent interactions of cytochrome c with the inner membrane, SS-31 optimizes electron transfer, reduces electron leak and reactive oxygen species (ROS) production, and improves ATP generation efficiency. In aged and diseased mitochondria where cardiolipin oxidation is prevalent, SS-31 restores bioenergetic function.

Research Applications

  • Studies have investigated mitochondrial function in primary mitochondrial myopathy research models (Barth syndrome)
  • Studies have examined cardiac function signaling in heart failure research models
  • Research has explored renal protective effects in ischemia-reperfusion injury models
  • Studies have assessed age-related mitochondrial dysfunction and skeletal muscle function signaling

Key Published Studies

1

Birk AV, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24(8):1250-1261.

Key finding: Demonstrated that SS-31 binds specifically to cardiolipin, restores electron transport chain function in ischemic mitochondria, and reduces ROS production while improving ATP synthesis.

2

Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050.

Key finding: Review establishing SS-31 as the first compound specifically designed to target and protect cardiolipin, with demonstrated efficacy in research models of heart failure, renal injury, and neurodegeneration.

Chemical Properties

TypePeptide (tetrapeptide, mitochondria-targeted)

Research Use Only (RUO): This page summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. The compound described carries a Research Use Only designation and is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in the diagnosis, treatment, cure, or prevention of any disease. Consult qualified professionals before making any health-related decisions.

i2b Health Research Supply
RESEARCH USE ONLY

Age Verification Required

You must be 21 years of age or older to access this website. All products are intended for qualified researchers and laboratory use only.

By entering this site, you confirm that you are at least 21 years of age, that anything you acquire here is for research purposes, and that you agree to our Terms of Service and Research Use Only policy. Products are not intended for human or animal consumption.